Danilov, Alexey V.
Spurgeon, Stephen E.
Siddiqi, Tanya
Quinson, Anne-Marie
Maier, Daniela
Smith, Dionne
Brown, Jennifer R. http://orcid.org/0000-0003-2040-4961
Funding for this research was provided by:
Boehringer Ingelheim (N/A)
Article History
Received: 26 October 2020
Accepted: 16 December 2020
First Online: 8 March 2021
Compliance with ethical standards
:
: AVD has received consulting fees from AstraZeneca, Abbvie, BeiGene, Genentech, TG Therapeutics, Janssen, Rigel Pharmaceutical, Nurix, Bayer Oncology, Karyopharm and Pharmacyclics and has ongoing research funding from AstraZeneca, Takeda Oncology, Gilead Sciences, Bayer Oncology, Genentech, Verastem Oncology, MEI and Bristol Myers Squibb. SES reports grants from Boehringer Ingelheim during the conduct of the study and personal fees from Pharmacyclics outside the submitted work. TS reports institutional funds fees from Boehringer Ingelheim during the conduct of the study; personal fees from AstraZeneca, PCYC, Janssen, Juno, Celgene, BeiGene and Kite Pharma outside the submitted work. AMQ, DM and DS are employees of Boehringer Ingelheim. JRB reports personal fees from Abbvie, Acerta/AstraZeneca, Astellas, BeiGene, Catapult Therapeutics, Dynamo Therapeutics, Genentech/Roche, Janssen, Juno/Celgene, Kite, MEI Pharma, Nextcea, Novartis, Octapharma, Pfizer, Pharmacyclics, Redx, Rigel, Sun, Sunesis, Teva, and TG Therapeutics; grants and personal fees from Gilead, Loxo/Lilly and Verastem outside the submitted work. She has sat on Data Safety Monitoring Boards for Invectys and Morphosys.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.